Spatio-temporal dependency of radiotherapy induced cardiac toxicity in a novel preclinical model

Lead Research Organisation: Queen's University Belfast
Department Name: Sch of Medicine, Dentistry & Biomed Sci

Abstract

Radiotherapy is an excellent treatment for many types of cancer and about half of all patients can be cured by its use. Despite its success, radiotherapy can result in harmful side effects which can have severe consequences on the quality of life and survival of patients following treatment. In particular, patients who receive chest radiotherapy for different cancers may develop unwanted side effects in the heart which can be life threatening.

In this project, we will investigate different strategies that may be capable of minimizing the effects of radiotherapy by optimising radiotherapy is delivered. This will focus on avoiding structures in the heart that are very sensitive to radiation and will use a new technique to deliver radiotherapy at very high dose rates called FLASH-RT. We will use this information to design better ways of delivering radiotherapy that will reduce harmful effects in the heart, allowing even higher doses of radiotherapy to delivered which could improve outcomes for patients.

Technical Summary

Radiation induced cardiac toxicity (RICT) is a major cause of morbidity and mortality in patients following radiotherapy for thoracic malignancies. The risk of developing RICT after treatment increases linearly with mean absorbed dose to the heart by >7% per Gy with an apparent low dose threshold. Consequently, no clear dose volume constraints can be defined & current radiotherapy planning recommendations advise dose to the heart be kept as low as possible.

Current clinical heart dose constraints remain poorly defined and are largely predicted on the heart being a uniformly radiosensitive organ. Recent clinical observations have shown a dose sensitive region in the base of the heart that is associated with poor survival outcomes in lung cancer. We have reverse translated these observations in a mouse model showing significant cardiac dysfunction following base irradiation of the heart.

In this project we will use this model to investigate the impact of spatio-temporal radiotherapy delivery parameters on RICT. Our overall aim to optimise treatment planning by integrating regional cardiac dose constraints based on radiosensitive sub-volumes, cardio-pulmonary interplay and effects at ultra-high dose rates (FLASH-RT).

Publications

10 25 50

publication icon
Friedl AA (2022) Radiobiology of the FLASH effect. in Medical physics

publication icon
Fukunaga H (2021) A Brief Overview of the Preclinical and Clinical Radiobiology of Microbeam Radiotherapy. in Clinical oncology (Royal College of Radiologists (Great Britain))

publication icon
Ghita-Pettigrew M (2024) Dose-dependent changes in cardiac function, strain and remodelling in a preclinical model of heart base irradiation. in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

publication icon
Verhaegen F (2023) Roadmap for precision preclinical x-ray radiation studies. in Physics in medicine and biology

publication icon
Walls GM (2023) Spatial Gene Expression Changes in the Mouse Heart After Base-Targeted Irradiation. in International journal of radiation oncology, biology, physics

publication icon
Walls GM (2022) Murine models of radiation cardiotoxicity: A systematic review and recommendations for future studies. in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

 
Description Atrial Natriuretic Peptide as a Biomarker and Therapeutic Target in Radiation Cardiotoxicity
Amount £33,481 (GBP)
Funding ID RCCPOB-Nov22/100010 
Organisation Cancer Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 02/2023 
End 02/2024
 
Description Establishing a UK National Preclinical Photon-FLASH Radiotherapy Facility (FLASH-SARRP)
Amount £798,610 (GBP)
Funding ID MC_PC_MR/X012433/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 09/2022 
End 03/2023
 
Title In vivo model of cardiac toxicity following base irradiation 
Description We have developed an In vivo model of cardiac toxicity following targetted irradiation of the heart base and application of spatial transcriptomic to assess gene expression changes. 
Type Of Material Database/Collection of data 
Year Produced 2023 
Provided To Others? Yes  
Impact In vivo model of cardiac toxicity following targetted irradiation of the heart base and application of spatial transcriptomic to assess gene expression changes 
URL https://doi.org/10.1016/j.ijrobp.2022.08.031
 
Description CRUK RADNET RADIOTHERAPY-DRUG COMBINATIONS TRAINING WORKSHOP 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact CRUK RadNet Radiotherapy-Drug Combinations Training Workshop attended by Post Doctoral Researchers and Clinical Oncologists
Year(s) Of Engagement Activity 2023
 
Description Invited speaker at online panel event - Xstrahl Life Sciences 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Industry/Business
Results and Impact Invited speaker at online panel event - Xstrahl Life Sciences
Year(s) Of Engagement Activity 2021
 
Description Particpation in Conference Talk - iNanoTheRad, Univserity of Paris Sud 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Postgraduate students
Results and Impact Talk at online conference (iNanoTherAD)
Year(s) Of Engagement Activity 2021
 
Description Patrick G Johnston Cancer Centre Open Day 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Schools
Results and Impact Cancer Centre Open Day that was attended by around 200 members of the public, patients, and caregivers.
Year(s) Of Engagement Activity 2023